Public interest groups, already harshly critical of the original deal for not going far enough, are outraged by the decision.

Proponents of waiving intellectual property rights argue that freeing the technology would lead to faster local production of live-saving jabs but the industry says this would wind up discouraging medical innovation.

World Trade Organization boss Ngozi Okonjo-Iweala is set to meet EU trade ministers for talks in Brussels.